Brought to you by 
Omrix Biopharmaceuticals nets $51.4mm in FOPO
12 Jan 2007
Executive Summary
Recently public Omrix Biopharmaceuticals (fibrin sealants and biosurgical products) brought in $51.4mm in a follow-on offering of 1.7mm shares (including the overallotment) at $32 apiece. Selling stockholders netted $22.6mm through the sale of an additional 750k shares.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Surgical Equipment & Devices
- Surgical Sealants
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Omrix Biopharmaceuticals nets $51.4mm in FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice